Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Horton, TM; Whitlock, JA; Lu, X; O'Brien, MM; Borowitz, MJ; Devidas, M; Raetz, EA; Brown, PA; Carroll, WL; Hunger, SP.
British Journal of Haematology.
2019;
186:274-285.
Capped antithrombin III dosing is cost effective in the management of asparaginase-associated thrombosis.
Young, J; Sawyer, J; Jenkins, M; O'Brien, M; Luchtman-Jones, L; Breese, EH.
Pediatric Blood and Cancer.
2019;
66:e27719-e27719.
Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Sopfe, J; Endres, A; Campbell, K; Hayes, K; Trout, AT; Liang, X; Lorsbach, R; O'Brien, MM; Cost, CR.
Pediatric Blood and Cancer.
2019;
66:e27613-e27613.
Delayed methotrexate clearance in patients with acute lymphoblastic leukemia concurrently receiving dasatinib.
Ramsey, LB; Mizuno, T; Vinks, AA; O'Brien, MM.
Pediatric Blood and Cancer.
2019;
66:e27618-e27618.
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Bhojwani, D; Sposto, R; Shah, NN; Rodriguez, V; Yuan, C; Stetler-Stevenson, M; O'Brien, MM; McNeer, JL; Quereshi, A; Cabannes, A; et al.
Leukemia.
2019;
33:884-892.
Significant effect of infection and food intake on sirolimus pharmacokinetics and exposure in pediatric patients with acute lymphoblastic leukemia.
Mizuno, T; O'Brien, MM; Vinks, AA.
European Journal of Pharmaceutical Sciences.
2019;
128:209-214.
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.
Gurunathan, A; Boucher, AA; Mark, M; Prus, KM; O'Brien, MM; Breese, EH; Mizukawa, BE; Absalon, MJ; Nelson, AS; Jordan, MB; et al.
Pediatric Blood and Cancer.
2018;
65:e27400-e27400.
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Gore, L; Locatelli, F; Zugmaier, G; Handgretinger, R; O'Brien, MM; Bader, P; Bhojwani, D; Schlegel, P; Tuglus, CA; von Stackelberg, A.
Blood Cancer Journal.
2018;
8.
Cost-Effectiveness Analysis of an Adherence-Promotion Intervention for Children With Leukemia: A Markov Model-Based Simulation.
McGrady, ME; Eckman, MH; O'Brien, MM; Pai, AL H.
Journal of Pediatric Psychology.
2018;
43:758-768.
Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.
Qi, Z; Gates, EL; O'Brien, MM; Trout, AT.
Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI.
2018;
48:196-203.